Detection of Mutated K- ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
dc.contributor.author | Su, Ying-Hsiu | en_US |
dc.contributor.author | Wang, Mengjun | en_US |
dc.contributor.author | Brenner, Dean E. | en_US |
dc.contributor.author | Norton, Pamela A. | en_US |
dc.contributor.author | Block, Timothy M. | en_US |
dc.date.accessioned | 2010-06-01T19:05:23Z | |
dc.date.available | 2010-06-01T19:05:23Z | |
dc.date.issued | 2008-08 | en_US |
dc.identifier.citation | Su, Ying-Hsiu; Wang, Mengjun; Brenner, Dean E.; Norton, Pamela A.; Block, Timothy M. (2008). "Detection of Mutated K- ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps." Annals of the New York Academy of Sciences 1137(1 Circulating Nucleic Acids in Plasma and Serum V ): 197-206. <http://hdl.handle.net/2027.42/72277> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72277 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18837947&dopt=citation | en_US |
dc.format.extent | 151088 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | © 2008 New York Academy of Sciences | en_US |
dc.subject.other | Urine DNA | en_US |
dc.subject.other | Circulating DNA | en_US |
dc.subject.other | Cancer Biomarkers | en_US |
dc.subject.other | K -Ras Mutations | en_US |
dc.subject.other | Cancer Detection | en_US |
dc.title | Detection of Mutated K- ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine and Pharmacology, 2150B Cancer and Geriatrics Center, University of Michigan Medical Center, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Department of Microbiology and Immunology, College of Medicine, Drexel University, Doylestown, Pennsylvania, USA | en_US |
dc.identifier.pmid | 18837947 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72277/1/annals.1448.027.pdf | |
dc.identifier.doi | 10.1196/annals.1448.027 | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Utting, M. et al. 2002. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin. Cancer Res. 8: 35 – 40. | en_US |
dc.identifier.citedreference | Hoque, M.O. et al. 2003. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res. 63: 5723 – 5726. | en_US |
dc.identifier.citedreference | Cairns, P. 2004. Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann. N.Y. Acad. Sci. 1022: 40 – 43. | en_US |
dc.identifier.citedreference | Dulaimi, E. et al. 2004. Promoter hypermethylation profile of kidney cancer. Clin. Cancer Res. 10: 3972 – 3979. | en_US |
dc.identifier.citedreference | Dulaimi, E. et al. 2004. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin. Cancer Res. 10: 1887 – 1893. | en_US |
dc.identifier.citedreference | Cairns, P. et al. 2001. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7: 2727 – 2730. | en_US |
dc.identifier.citedreference | Papadopoulou, E. et al. 2004. Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer. Oncol. Res. 14: 439 – 445. | en_US |
dc.identifier.citedreference | Su, Y.H. et al. 2004. Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J. Mol. Diagn. 6: 101 – 107. | en_US |
dc.identifier.citedreference | Botezatu, I. et al. 2000. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin. Chem. 46: 1078 – 1084. | en_US |
dc.identifier.citedreference | Serdyuk, O.I. et al. 2001. Detection of mutant k-ras sequences in the urine of cancer patients. Bull. Exp. Biol. Med. 131: 283 – 284. | en_US |
dc.identifier.citedreference | Taback, B. & Hoon, D.S.B. 2004. Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Ann. N.Y. Acad. Sci. 1022: 1 – 8. | en_US |
dc.identifier.citedreference | Chan, A.K.C. et al. 2003. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann. Clin. Biochem. 40: 122 – 130. | en_US |
dc.identifier.citedreference | Lo, Y.M. et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485 – 487. | en_US |
dc.identifier.citedreference | Nawroz, H. et al. 1996. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2: 1035 – 1037. | en_US |
dc.identifier.citedreference | Chen, X.Q. et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2: 1033 – 1035. | en_US |
dc.identifier.citedreference | Goessl, C. et al. 1998. Microsatellite analysis of plasma DNA from patients with clear renal carcinoma. Cancer Res. 58: 4728 – 4732. | en_US |
dc.identifier.citedreference | Wong, I.H.N. et al. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59: 71 – 73. | en_US |
dc.identifier.citedreference | Esteller, M. et al. 1999. Detection of abbertant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59: 67 – 70. | en_US |
dc.identifier.citedreference | Pathak, A.K. et al. 2006. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin. Chem. 52: 1833 – 1842. | en_US |
dc.identifier.citedreference | Shapiro, B. et al. 1983. Determination of circulating DNA Levels in patients with benign of malignant gastrointestinal disease. Cancer 51: 2116 – 2120. | en_US |
dc.identifier.citedreference | Maltzman, T. et al. 2001. Ki- ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 121: 302 – 309. | en_US |
dc.identifier.citedreference | Ahlquist D.A. et al. 2000. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119: 1219 – 1227. | en_US |
dc.identifier.citedreference | Rashid, A. et al. 2002. K- ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin. Cancer Res. 8: 3156 – 3163. | en_US |
dc.identifier.citedreference | Vogelstein, B. et al. 1998. Genetic alterations during colorectal-tumor development. New Engl. J. Med. 319: 525 – 532. | en_US |
dc.identifier.citedreference | Andersen, S. et al. 1999. Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K- ras mutations. Gut 45: 686 – 692. | en_US |
dc.identifier.citedreference | Otori, K. et al. 1997. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 40: 660 – 663. | en_US |
dc.identifier.citedreference | Takayama, T. et al. 2001. Analysis of K- ras, APC, and B- catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121: 599 – 611. | en_US |
dc.identifier.citedreference | Przybojewska, B. et al. 2000. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet. Cytogenet. 121: 73 – 77. | en_US |
dc.identifier.citedreference | Su, Y.H. et al. 2004. Transrenal DNA as a diagnostic tool: important technical notes. Ann. N.Y. Acad. Sci. 1022: 81 – 89. | en_US |
dc.identifier.citedreference | Wang, M. et al. 2004. Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin. Chem. 50: 211 – 213. | en_US |
dc.identifier.citedreference | Chan, K.C.A. et al. 2003. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 63: 2028 – 2032. | en_US |
dc.identifier.citedreference | Taback, B. et al. 2004. Quantification of circulating DNA in the plasma and serum of cancer patients. Ann. N.Y. Acad. Sci. 1022: 17 – 24. | en_US |
dc.identifier.citedreference | Jorg, H.H. et al. 2004. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy. Ann. N.Y. Acad. Sci. 1022: 271 – 281. | en_US |
dc.identifier.citedreference | Koffler, D. et al. 2006. The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J. Clin. Invest. 52: 198 – 204. | en_US |
dc.identifier.citedreference | Leon, S.A. et al. 1997. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37: 646 – 650. | en_US |
dc.identifier.citedreference | Steinman, C.R. 1982. Circulating DNA in polyarteritis nodosa and related syndromes. Arthritis Rheum. 25: 1425 – 1430. | en_US |
dc.identifier.citedreference | Steinman, C.R. 1984. Circulating DNA in systemic lupus erthematosus. J. Clin. Invest. 73: 832 – 841. | en_US |
dc.identifier.citedreference | Neurath, A.R. et al. 1994. Strategies for detection of transfusion-transmitted viruses eluding identification by conventional serologic tests II. Detection of host DNA in human plasmas with elevated alanine aminotransferase. J. Virol. Methods 8: 73 – 86. | en_US |
dc.identifier.citedreference | Jahr, S. et al. 2001. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61: 1659 – 1665. | en_US |
dc.identifier.citedreference | Anker, P. et al. 1999. Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients. Cancer Metast. Rev. 18: 65 – 73. | en_US |
dc.identifier.citedreference | Arai, N. et al. 1999. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Modern Pathol. 12: 604 – 611. | en_US |
dc.identifier.citedreference | Nakamura, T. et al. 1995. Cell death in colorectal polyps as evaluated by in situ 3′-tailinig reaction and its relationship to BCL-2 expression. Pathol. Int. 45: 721 – 728. | en_US |
dc.identifier.citedreference | Schulte-Hermann, R. et al. 1995. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol. Lett. 82/83: 143 – 148. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.